Future research should focus on exploring the specific mechanisms of the cGAS-STING pathway in different breast cancer subtypes, developing precise biomarkers and diagnostic tools, optimizing modulator development and application strategies, investigating multidisciplinary comprehensive treatment models, and identifying effective ways to overcome tumor heterogeneity and drug resistance. Here, STING1 is linked to neoplasm.